Introduction

vet00301

Company name: Boehringer Ingelheim Limited

Address: Ellesfield Avenue

Bracknell

Berkshire RG12 8YS

Telephone: Sales & Marketing Enquiries 01344 746959

Telephone: Technical Enquiries 01344 746957

Fax: 01344 741349

Presentation

Each 5 ml UBRO YELLOW Milking Cow Intramammary injector contains:

Penethamate hydriodide	150 mg
Dihydrostreptomycin Sulphate (equivalent to Dihydrostreptomycin 150mg)	185 mg
Framycetin Sulphate	50 mg
Prednisolone	5 mg

in an off-white sterile ointment base.

Uses

UBRO YELLOW contains a combination of antibiotics which give a wide spectrum of in vitro antibacterial activity for the treatment of bovine mastitis associated with penicillin, streptomycin and framycetin sensitive organisms.These include staphylococci (including penicillin resistant strains), streptococci (Str. agalactiae, Str. dysgalactiae and Str. uberis), corynebacteria, Arcanobacterium pyogenes, E. coli, Klebsiella and Pseudomonas.

Dosage and administration

Infuse one injector every 24 hours for three days, into the affected quarter after milking, using strict aseptic precautions. Before infusion the teat should be thoroughly cleaned and disinfected and care should be taken to avoid contamination of the injector nozzle. Following infusion it is advisable to use a teat dip or spray.

Contra-indications, warnings, etc

For animal treatment only.

Animals must not be slaughtered for human consumption during treatment. Cattle may be slaughtered for human consumption only after 28 days from the last treatment. Milk for human consumption must not be taken from a cow during treatment. With cows milked twice daily, milk for human consumption may only be taken from 132 hours (i.e. at the 11th milk milking) after the last treatment. With other milking routines, the basis of the Veterinary Surgeon’s advice should be that milk may be taken for human consumption only after the same period from the last treatment. For example with three times a day milking, milk for human consumption may be taken at the 16th milking after the last treatment.

Penicillins and cephalosporins may cause hypersensitivity (allergy) following injection, inhalation, ingestion or skin contact. Hypersensitivity to penicillins may lead to cross reactions to cephalosporins and vice versa. Allergic reactions to these substances may occasionally be serious.

(1) Do not handle this product if you know you are sensitised, or if you have been advised not to work with such preparations.

(2) Handle the product with great care to avoid exposure, taking all recommended precautions.

(3) If you develop symptoms following exposure such as a skin rash, you should seek medical advice and show the doctor this warning. Swelling of the face, lips or eyes or difficulty with breathing are more serious symptoms and require urgent medical attention.

During the course of treatment, the situation should be reviewed frequently by close veterinary supervision.

Wash hands after use.

Keep out of the reach and sight of children.

Pharmaceutical precautions

Do not store above 25°C.

The syringe must only be used once. Part used syringes must be discarded. Dispose of any unused product and empty containers in accordance with guidance from your local waste regulation authority.